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Background: The group A Streptococcus (GAS) M1 protein binds fibrinogen (Fg) to block phagocytosis and to form a
proinflammatory complex.
Results:M1 and Fg limit GAS adherence and invasion of pharyngeal keratinocytes in vitro.
Conclusion: Protease SpeB modulates M1 expression and GAS host cell interactions differentially during the course of
infection.
Significance:M1 protein is shown to impede pharyngeal colonization in vivo.
Group A Streptococcus (GAS) is a leading human pathogen
producing a diverse array of infections from simple pharyngitis
(“strep throat”) to invasive conditions, including necrotizing
fasciitis and toxic shock syndrome. The surface-anchored GAS
M1 protein is a classical virulence factor that promotes phago-
cyte resistance and exaggerated inflammation by binding host
fibrinogen (Fg) to form supramolecular networks. In this study,
weused a virulentWTM1T1GAS strain and its isogenicM1-de-
ficient mutant to examine the role of M1-Fg binding in a proxi-
mal step in GAS infection-interaction with the pharyngeal epi-
thelium. Expression of the M1 protein reduced GAS adherence
to human pharyngeal keratinocytes by 2-fold, and this differ-
ence was increased to 4-fold in the presence of Fg. In stationary
phase, surfaceM1protein cleavage by theGAScysteine protease
SpeB eliminated Fg binding and relieved its inhibitory effect on
GAS pharyngeal cell adherence. In a mouse model of GAS colo-
nization of nasal-associated lymphoid tissue, M1 protein
expressionwas associatedwith an average 6-fold decreasedGAS
recovery in isogenic strain competition assays. Thus, GAS M1
protein-Fg binding reduces GAS pharyngeal cell adherence and
colonization in a fashion that is counterbalanced by SpeB. Inac-
tivation of SpeB during the shift to invasive GAS disease allows
M1-Fg binding, increasing pathogen phagocyte resistance and
proinflammatory activities.
The Gram-positive bacterium Streptococcus pyogenes, also
known as groupA Streptococcus (GAS),2 is an important, exclu-
sively human pathogen that is responsible for many clinical
diseases, ranging from simple pharyngitis (“strep throat”) to
life-threatening invasive conditions such as necrotizing fasciitis
and streptococcal toxic shock-like syndrome (1, 2). Further-
more, repeated GAS infection can provoke serious autoim-
mune sequelae, including acute glomerulonephritis, rheumatic
fever, and rheumatic heart disease; the latter remains a leading
cause of morbidity and mortality in many parts of the develop-
ing world (3). Although oral antibiotic therapy is effective for
noninvasiveGAS infections such as pharyngitis, severe invasive
GAS diseases typically require aggressive supportive care and
surgical interventions (4, 5). To date, a safe and efficacious GAS
vaccine has yet to be developed (6, 7).
GAS strains are classified by serotype based on the M
protein, an antigenically variable surface-anchored protein
encoded by the emm gene (8, 9). M proteins possess a highly
conserved C-terminal region that is required for covalent cell
surface attachment and a highly variableN-terminal region that
extends outwards from the cell wall (10, 11). M proteins form
surface fibrils, with almost their entire length appearing to form
a dimeric -helical coiled coil (12). Serotype specificity occurs
within the hypervariable N-terminal region of 40–50 amino
acid residues, and200 emm sequence types have been identi-
fied (13). Serotype M1 is consistently among the most com-
monly identified serotypes in streptococcal pharyngitis (14)
and invasive diseases worldwide (3, 15). Since the 1980s, a
marked worldwide resurgence in severe invasive GAS diseases,
including streptococcal toxic shock-like syndrome and necro-
tizing fasciitis, has been correlated with the global dissemina-
tion of a single GAS serotype, the M1T1 clone (16, 17).
After colonization of the epithelium, the bacteria penetrate
the subepithelial tissue, where neutrophils are recruited and
exert a selective pressure to which the bacteria must adapt for
the infection to proceed into the blood. This transition from
localized to systemic infection by GAS serotypeM1T1 involves
spontaneous mutations within the CovRS two-component sys-
tem, which regulates 10% of the GAS genome, resulting in
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strong transcriptional up-regulation of multiple virulence-as-
sociated genes (2, 18). The up-regulated genes include the
operon for synthesis of the hyaluronic acid capsule and the
genes encoding streptolysin O, NAD glycohydrolase, the
interleukin-8 protease SpyCEP/ScpC, and the DNase Sda1.
These mutations in the covRS operon also abolish expression
of streptococcal pyrogenic exotoxin B (SpeB), a broad-spec-
trum, secreted cysteine protease (19) that can degrade sev-
eral GAS extracellular proteins and virulence factors (20).
Loss of SpeB protease activity prevents degradation of strep-
tokinase (a plasminogen activator), the M1 surface protein,
and host plasminogen, enabling GAS serotype M1T1 to
accumulate cell surface plasmin activity via M1-bound
fibrinogen (Fg) and promote invasive infection by enhancing
bacterial dissemination (21).
M proteins mediate GAS resistance to opsonophagocytosis
by binding Fg, complement inhibitor factor H, and C4BP (C4b-
binding protein) to the GAS cell surface (22–24). Surface-
bound Fg masks receptors for complement protein C3b,
whereas factor H down-regulates the production of C3b, as
does C4BP. Together, C3b deposition on the GAS cell surface
and C3b interaction with neutrophils are blocked. Further-
more, after proteolytic release from the GAS surface, the M1
type of theMprotein forms a proinflammatory supramolecular
network with Fg that contributes to the pathophysiology of
streptococcal toxic shock-like syndrome (25, 26).
A proximal step in the pathogenesis of GAS infection is col-
onization of the pharyngeal epithelium. Whereas M protein
binding to Fg promotes immune evasion by reducing phago-
cytic cell interactions, the effect of this phenomenon on GAS
interaction with epithelial cells has not yet been described. Col-
onization of epithelial cells is initially a weak interaction medi-
ated by lipoteichoic acid or pili, followed by a stronger binding
via lectin-carbohydrate and/or protein-protein interactions
that confer tissue specificity. Fibronectin has been demon-
strated to serve as a receptor for many GAS adhesion proteins
(27). M proteins can interact with extracellular matrix proteins
and therefore promote epithelial cell adherence (27–31). How-
ever, this function may depend on the M serotype and target
cell; for example, M6 and M24 proteins mediate adherence of
GAS to human soft palate, whereas M18 does not (32). These
considerations led us to study how the M1 protein (and in par-
ticular, its ability to bind Fg) influences pharyngeal epithelial
interactions during early GAS infection.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
GAS serotype M1T1 isolate 5448 (WT) was originally iso-
lated from a patient with necrotizing fasciitis and toxic shock
(33). The isogenic in-frame allelic exchange knock-out
mutants 5448emm1 (M1) (34) and 5448speB (SpeB)
(35) have been described previously. All GAS strains were
routinely propagated at 37 °C on Todd-Hewitt agar (Difco)
or in static liquid cultures of Todd-Hewitt broth. Where
appropriate, strains were grown in medium supplemented
with 5 g/ml erythromycin.
Assays for Bacterial Fg binding
Flow Assay—Fg (human plasminogen-depleted; Calbi-
ochem) was labeled with FITC using the FluoReporter protein
labeling kit (Invitrogen) and added at 100g/ml to GAS strains
grown toA600 0.4 in Todd-Hewitt broth. Samples were incu-
bated for 30 min with rotating and washed with PBS prior to
flow cytometric analysis. The percentage of cells bound by Fg
was determined relative to the WT strain.
Plate-based Assay—Microtiter plates were coated overnight
at 4 °C with 200 l of Fg at 0.2 mg/ml in 50 mM Na2CO3 (pH
9.5). The wells were washed three times with PBS and blocked
with 1% bovine serum albumin for 2 h at 37 °C. Then, 100 l of
2  108 bacteria were added and spun at 500  g for 10 min.
Plates were incubated at 37 °C for 1 h; the supernatant was
removedwith a pipette andwashed five timeswith PBS; and 100
l of 0.25% trypsin  1 mM EDTA were added. Plates were
incubated at 37 °C for an additional 10 min, and 100 l of PBS
was added, followed by trituration 50 times. Serial dilutions
were plated onto Todd-Hewitt agar plates for cfu enumeration.
Fg-bound Inoculum—Log-phase group A streptococci were
incubated with or without 8 g/ml Fg for 30 min, and serial
dilutions were plated to enumerate cfu in the presence or
absence of Fg.
Adherence and Invasion Assays, Including Fluorescence
Microscopy
Adherence and invasion assays were performed as described
previously (36) but using the HaCaT human skin keratinocyte
cell line or theOKP7/tert pharyngeal keratinocyte cell line (37),
a generous gift from the Harvard Skin Disease Research Center
Cell Culture Core (J. Rheinwald, Director). OKP7 cells were
first grown to 80% confluence in keratinocyte serum-free
medium (Invitrogen) 25g/ml bovine pituitary extract 0.2
ng/ml EGF 0.3mMCa2. The cell were then split into 24-well
plates and cultivated in 1:1 Dulbecco’s modified Eagle’s
medium and Ham’s F-12 nutrient mixture 0.2 ng/ml EGF
25 g/ml bovine pituitary extract 2 mM L-glutamine with or
without 8g/ml Fg. HaCaT cells were cultivated in RPMI 1640
medium  10% FBS. GAS strains in the logarithmic growth
phase (A600  0.4) or stationary phase (21-h growth) were
resuspended in PBS and added to the keratinocyte cells at a
multiplicity of infection of 10. Imaging analysis was performed
using FITC-labeled GAS (30-min treatment with 0.2 mg/ml
FITC, covered on ice, andwashedwith PBS). Imageswere taken
using a Zeiss Axiovert 40 CFL microscope, 10 Achroplan or
32 Achrostigmat objectives, a Zeiss AxioCam MR camera,
and AxioVision AC software and processed in Photoshop to
overlap the FITC signal with the bright-field image.
Mouse Nasal-associated Lymphoid Tissue (NALT) Colonization
Assay
Mice were inoculated as described previously (38). Briefly,
GAS were grown to A600  0.4 and resuspended to 2  107
cfu/l in PBS. GAS were mixed at a 1:1 ratio of WT to M1
bacteria or complementedmutant toM1bacteria; 10l of the
1:1mixture were pipetted into each nostril (20l/mouse 4
108 cfu total) of 8–12-week-old C57BL/6 mice under anesthe-
sia; the inoculum was allowed to dry. Mice were killed 24 h
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post-infection; theNALTwas dissected as described previously
(38) and homogenized in PBS; and serial dilutions were plated
onto blood agar, Todd-Hewitt agar 5g/ml erythromycin, or
Todd-Hewitt agar 2 g/ml chloramphenicol plates for enu-
meration of cfu. For histopathological studies, NALT was dis-
sected, paraffin-sectioned and Gram-stained. Images were
taken using aMotic BA400microscope, aMotic 40 objective,
a Moticam 2500 camera, and Motic Images Plus 2.0 software.
Ethics Statement
This study was carried out in strict accordance with the rec-
ommendations in theGuide for the Care andUse of Laboratory
Animals of the National Institutes of Health. The protocol
was approved by the Institutional Animal Care and Use Com-
mittee at the University of California, San Diego (Animal Wel-
fare Assurance A3033-01). All efforts were made to minimize
the suffering of the animals employed in this study.
RESULTS
M1 Protein Is the Major Fg-binding Protein of M1T1 GAS
Strain 5448—Previous studies have demonstrated the impor-
tance of Fg binding by surface-expressedMproteins in restrict-
ing complement deposition and blocking GAS opsonophago-
cytosis (22, 28, 39). In addition, recent work has shown that the
contribution of the M1 protein to GAS systemic virulence is
dependent on the serum concentration of Fg (40). As a first step
in our analysis, we tested the contribution of the M1 protein to
Fg binding byWTM1T1GAS strain 5448, representative of the
contemporary hypervirulent clone associated with pharyngitis
and invasive infections worldwide. In a flow cytometry-based
assay using fluorescently labeled Fg,WTM1T1GAS hadmark-
edly higher levels of Fg binding than the isogenic M1mutant,
and reintroduction of theM1 protein on a plasmid vector to the
M1 mutant strain (complemented mutant) restored the WT
Fg binding level (Fig. 1A). Thus, M1 serves as the major Fg-
binding protein in our M1T1 strain. Similarly, we asked
whether the M1 protein is sufficient for Fg binding in heterol-
ogous expression studies in nonpathogenic Lactococcus lactis
(Fig. 1B). No Fg binding was detected in L. lactis harboring an
empty vector control in a plate-based assay. In contrast, Fg
binding was markedly increased in L. lactis transformed with a
plasmid expressing theWTM1 protein, but not M1 lacking its
three main Fg-binding sites (M1Fg) (26). Thus, as expressed
on the surface of intact bacteria, the M1 protein is both neces-
sary and sufficient for Fg binding.
M1Protein Reduces Pharyngeal Cell Adherence and Invasion,
with Binding to Fg Further Reducing Adherence—To date, the
role of Fg binding by the M protein in GAS virulence has been
analyzed inmodels of systemic infection such as blood survival,
resistance to phagocytic killing, and endothelial cell interac-
tions (24–26, 34, 39, 40). Here, we examined the effect of the
M1 protein and its Fg-binding property on M1T1 GAS adher-
ence to and invasion of pharyngeal epithelial cells, a critical first
step in the pathogenesis of localized and systemic infections.
For these studies, we analyzed the immortalized pharyngeal
keratinocyte cell line OKP7/tert (hereafter referred to as
OKP7), as previous work employed the Hep-2 line now recog-
nized to be HeLa cells by karyotypic analysis (41). Interestingly,
we found that the M1 mutant showed increased pharyngeal
epithelial cell adherence (Fig. 2A) and invasion (Fig. 2B) com-
pared with the WT parent GAS strain. This finding was con-
sistent with our analysis of the adherence to and invasion of
HaCaT skin keratinocytes (Fig. 3, A and B) and previous find-
ings in the HaCaT cell line (42).
Normal Fg levels in human serumaverage3mg/ml (43, 44),
and Fg is detected in human sputum (2–20 g/ml) (45) and
saliva (46) and is localized onhuman tonsils (47).Upon addition
of Fg at a conservatively low level of 8g/ml (1/750th of normal
serum levels), we observed a further reduction in OKP7 cell
adherence by theWT and complemented mutant GAS strains,
but not the M1 mutant (Fig. 2A), consistent with our finding
that the M1 strain does not bind Fg (Fig. 1A). Although M1
inhibited intracellular invasion ofOKP7 cells, the addition of Fg
did not alter the level of inhibition (Fig. 2B). To verify that the
observed effect of Fg was not due to GAS clumping resulting in
reduced cfu, we incubatedWTandM1GASwith andwithout
8 g/ml Fg and found no effect on GAS cfu recovery (Fig. 1C).
We conclude that the M1 protein (and in particular, its ability
to bind Fg) limits GAS adherence to pharyngeal keratinocytes
in vitro. These findingswere corroborated through direct imag-
ing of FITC-labeled GAS bound to OKP7monolayers (Fig. 2C).
To further explore the effect of M1 protein-Fg binding on
GAS pharyngeal cell adherence, we examined the L. lactis
strains expressing M1 and its Fg binding-deficient variant
(M1Fg). In the non-virulent, non-adherent L. lactis back-
FIGURE 1.M1 protein is the major Fg-binding factor of M1T1 GAS strain
5448. A, flow cytometric analysis of WT and M1 mutant GAS with FITC-
labeled Fg: WT (red), WT FITC-Fg (blue), M1 FITC-Fg (green), and com-
plementedmutant (Comp) FITC-Fg (orange).The bar graph shows quantifi-
cation of the flow cytometry results. B, quantification of Fg binding by L. lactis
strains expressing WT and Fg binding-deficient mutant versions of the M
protein, expressed as a percentageof the original inoculum recoveredbound
to an Fg-coated plate. C, quantification of the GAS inoculum after binding to
8 g/ml Fg. Assays were performed in triplicate and repeated three inde-
pendent times. ***, p  0.005 (one-way analysis of variance). n.s., not
significant.
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ground, expression of the M1 protein increased adherence,
although not to the level observed with GAS (7.6% versus 60.3%
of inoculum) (Figs. 2A and 3C), indicating that the M1 protein
can promote adherence to pharyngeal cells in the absence of
other GAS adherence factors. This increase in adherence was
markedly diminished when Fg was added (Fig. 3C). Heterolo-
gous expression of M1Fg in L. lactis increased OKP7 cell
adherence in a fashion that was not inhibited by Fg, showing
that the Fg effect on adherencewasmediated by theM1 protein
(Fig. 3C). We did not observe any significant effects on L. lactis
FIGURE 2.M1 protein-Fg binding reduces adherence to pharyngeal keratinocytes. Shown are the adherence to (A) and invasion of (B) OKP7 pharyngeal
keratinocytes by logarithmic phase WT and M1 mutant GAS in the presence or absence of 8 g/ml Fg, normalized to the inoculum. C, bright-field and
fluorescencemicroscopy of FITC-labeled GAS adherence to OKP7 cells. FITC channel images weremergedwith bright-field images in Photoshop. Adherence/
invasion assays were done in triplicate using triplicate sample wells. **, p 0.01; ***, p 0.005 (Student’s t test). Comp, complemented mutant.
FIGURE 3.M1 protein is sufficient to promote bacterial Fg binding and pharyngeal cell adherence, but differential effects are absent in stationary
phase GAS. Shown are the adherence to (A) and invasion of (B) HaCaT skin keratinocytes by logarithmic phase WT andM1mutant GAS. Also shown are the
adherence to (C) and invasionof (D) OKP7pharyngeal epithelial cells by logarithmicphase L. lactis expressingM1protein constructs in thepresenceor absence
of 8g/ml Fg, normalized to the inoculum.Adherence/invasionassayswereperformed in triplicate and repeated independently three times. *,p0.05; **,p
0.01; ***, p 0.005 (Student’s t test). ns, not significant.
Fg-bindingM1 Protein Reduces GAS Pharyngeal Colonization
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OKP7 cell invasion attributable to the M1 protein or Fg (Fig.
3D). We conclude that M1 protein binding to Fg reduces pha-
ryngeal cell adherence in both native GAS and the L. lactis het-
erologous expression systems.
We next examined the growth phase dependence of M1 and
Fg binding effects on pharyngeal cell adherence. Of note, we
found that stationary phaseWT andM1 and stationary phase
GAS had similar levels of OKP7 cell adherence and invasion in
the presence and absence of Fg (Fig. 4, A and B), in contrast to
the differences detected in log phase growth (Fig. 2, A and B).
Thus, the differences between WT and M1 detected in loga-
rithmic phase were lost in stationary phase.
SpeB Proteolysis Reduces M1 Protein-dependent Effects on
GAS Pharyngeal Cell Adherence—Expression of SpeB, a highly
conserved broad-spectrum GAS protease (48) that cleaves M1
and other GAS target proteins, has been shown to influence
surface expression of the GAS M1 protein in a growth phase-
dependent manner. SpeB is expressed only in late logarithmic
and stationary growth phase, leading to selective loss of surface
M1 protein during stationary phase (20, 49, 50). We hypothe-
sized that SpeB cleavage of surface M1 protein might account
for the loss of Fg dependence on adhesion of M1T1 GAS. To
understand the role of SpeB in GAS pharyngeal cell adherence,
we examined SpeB, a mutant generated in the same isogenic
GAS background as M1 (35) that allows the M1 protein to be
preserved in all growth phases (20, 50). As predicted, elimina-
tion of SpeB to preserve M1 surface expression markedly
increased stationary phase Fg binding to the GAS surface com-
pared with the negligible binding of Fg by the WT and M1
strains (Fig. 4C).We also found that stationary phase adherence
of the SpeB mutant was susceptible to inhibition by Fg (Fig.
4D). These data support a model in which Fg bound to surface
M1 protein limits epithelial cell adherence, which is counter-
acted in stationary phase by SpeB-mediated degradation of M1
(49, 50) and Fg itself (51). Tomore directly ascertain the effects
of SpeB on adherence and invasion, we treated logarithmic
phase cultures with recombinant SpeB protease. We observed
an increase in the adherence and invasion of SpeB-treated log-
arithmic phase WT GAS relative to the untreated control (Fig.
4, E and F). This increase in adherence and invasion matched
levels seen in the M1mutant, suggesting that SpeB treatment
is functionally equivalent to genetic ablation of M1 with regard
to pharyngeal cell adherence and invasion phenotypes. Addi-
tionally, SpeB-treatedWT GAS was not susceptible to Fg inhi-
bition, similar to the M1mutant (Fig. 4E). Finally, we did not
detect a significant difference when treating M1 with SpeB,
indicating that themajor effect of SpeB onOKP7 cell adherence
and invasion ismediated through cleavage ofM1protein (Fig. 4,
E and F).
M1 Protein Reduces GAS Colonization in a Mouse Upper
Respiratory Tract Challenge Model—Because our combined
studies in the tissue culture model indicated that M1 protein
binding to Fg limitsGASpharyngeal cell adherence, we hypoth-
esized that this phenotype could influence the pathogenesis of
FIGURE 4. SpeB cleavage of the M1 protein counteracts M1- and Fg-mediated reductions in pharyngeal epithelial cell adherence. Shown are the
adherence to (A) and invasion of (B) OKP7 pharyngeal keratinocytes by stationary phase WT and M1mutant GAS in the presence or absence of 8 g/ml Fg
(adherence only), normalized to the inoculum. C, left, flow cytometric analysis of stationary phaseM1T1 GAS 5448 strains with FITC-labeled Fg: WT (red), WT
FITC-Fg (blue), M1  FITC-Fg (green), and SpeB  FITC-Fg (orange). Right, quantification of flow cytometry with the GAS 5448 strains. D, adherence of
stationary phaseSpeBmutant GAS to OKP7 pharyngeal epithelial cells in the presence or absence of 8g/ml Fg, normalized to the inoculum. Shown are the
adherence to (E) and invasion of (F) logarithmic phaseGAS toOKP7 cells in the presence or absence of 8g/ml Fg (adherence only) and 10g/ml recombinant
SpeB, normalized to the inoculum. Fg binding assays were performed in triplicate and repeated three independent times. ***, p 0.005 (one-way analysis of
variance). Adherence and invasion assayswere performed in triplicate and repeated three independent times. *, p 0.05; **, p 0.01; ***, p 0.005 (Student’s
t test).
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GASpharyngeal colonization/infection in vivo.MouseNALT is
thought to resemble and serve as a functional equivalent of
human oropharyngeal lymphoid tissue (tonsils). It serves as a
conduit to pulmonary tissues for respiratory pathogens and is
the predominant source of GAS after nasal infection (38, 52).
We utilized a competitive colonization assay to determine
whether the M1 GAS mutant displayed an in vivo advantage
in NALT colonization as a result of increased adherence and
invasion of pharyngeal keratinocytes. We chose a competitive
model to overcome the differential effects betweenmice caused
by the antigenic and proinflammatory properties ofMproteins;
in the competition model, WT and M1 mutant bacteria are
subject to the same magnitude and character of localized host
response. C57BL/6 mice were infected intranasally with a 1:1
mixture of either (a) WT GAS versus M1 mutant or (b) M1
mutant versus complementedmutant (Fig. 5A). NALTwas col-
lected at 24 h post-infection, a time point at which histology
confirmed the presence of abundant GAS within infected
NALT (Fig. 5B) compared with the absence of bacteria in unin-
fected tissue (Fig. 5C). Differential plating was used to deter-
mine the number of viable GAS recovered for each strain (Fig.
5A). In the first competition assay, the ratio of M1 mutant
GAS toWTGAS recovered from14 differentmice ranged from
1.4:1 up to 48.8:1 (median  6.4:1) (Fig. 5D). In the second
competition assay, the ratio of M1 mutant GAS to comple-
mented mutant GAS recovered from 14 different mice ranged
from 1.3:1 to 9.2:1 (median 2.8:1) (Fig. 5E). These data clearly
indicate a survival advantage of the M1 mutant strain com-
pared with theWT or complemented mutant strain in a short-
term upper respiratory tract (NALT) colonization model, a
finding that is compatible with Fg binding by the M1 protein
limiting pharyngeal cell adherence.
DISCUSSION
In this work, we have shown that theM1 protein is themajor
Fg-binding protein for the globally disseminated M1T1 GAS
clone and is sufficient to promote Fg binding when heterolo-
gously expressed in a nonpathogenic Gram-positive bacterium.
Fg binding toGAShas been shownpreviously to protect against
phagocytosis (22, 28, 39), andM1-Fg supramolecular networks
activate neutrophils in a proinflammatory cascade that contrib-
utes to the pathogenesis of streptococcal toxic shock-like syn-
drome (25, 26, 40). These Fg-dependent properties establish
the M1 protein as a virulence factor that promotes bacterial
dissemination in vivo and fuels the systemic toxicity associated
with severe invasive M1T1 GAS infection. In a different con-
text, we found that Fg binding by the M1 protein limits GAS
adherence to pharyngeal epithelial cells in vitro and NALT col-
onization in vivo. Establishment of GAS infection in themurine
NALT model required a large bolus inoculum, which almost
certainly triggers increased immune stimulation compared
with the initial stages of human pharyngeal colonization. How-
ever, the data from this model were consistent with our adher-
ence findings obtained in experiments using cultured human
pharyngeal keratinocytes, which were performed at Fg concen-
trations found in the human pharyngeal microenvironment.
Thus, we infer that our findings may be relevant to human
pharyngeal colonization. The membrane cofactor protein
CD46 has been reported to serve as a skin keratinocyte receptor
for the conserved C repeat regions of the GAS M protein (53),
and perhaps Fg binding by M1 interferes with this interaction.
Themarkedly increased concentration of Fg in the blood versus
the sputum (3 mg/ml versus 2 g/ml, respectively) indicates
that the effects ofM1-Fg binding to retardGAS phagocytosis or
FIGURE 5.M1protein reduces NALT colonization in amurine infectionmodel. A, schematic of the infectionmodel. Micewere nasally inoculatedwith a 1:1
mixture of two GAS strains, and NALT tissue was harvested at 24 h post-infection, homogenized, and plated on selective media. Cm, chloramphenicol; Em,
erythromycin; abx, antibiotics. B, histological section of GAS-infected NALT tissue (Gram-stained). The arrows point to clusters of GAS. C, histological section of
uninfected NALT tissue (Gram-stained). D, plot of the ratio of recovered M1 GAS to WT GAS.E, samples in which WT GAS was below detectable levels (limit
of detectionused for ratio calculation). Thedashed line indicates a 1:1 ratio. E, plot of the ratioof recoveredM1GAS to complementedmutantGAS. Thedashed
line indicates a 1:1 ratio.
Fg-bindingM1 Protein Reduces GAS Pharyngeal Colonization
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promote inflammation are likely more intensive than its effects
on pharyngeal colonization.
During the transition from localized to invasive M1T1
GAS infection, data from human isolates and mouse chal-
lenge studies indicate that mutants in the covRS two-compo-
nent regulator arise under innate immune selection, altering
the expression of multiple virulence factors and promoting a
bloodstream-resistant phenotype (2, 18, 54, 55). AlthoughM
protein gene transcription itself is not significantly changed
upon covRSmutation, two of the more striking changes in vir-
ulence phenotypes are up-regulation of the expression of the
hyaluronic acid capsule and ablation of SpeB expression.
Hyperencapsulation of the invasive covRS mutant promotes
resistance to phagocytic clearance (56–58), yet the increase in
hyaluronic acid coating has also been shown to limit M1 GAS
epithelial cell adherence, biofilm formation, and in vivo coloni-
zation of skin (59).
We found that because SpeB cleaves the M protein from the
GAS surface, it can mitigate the inhibitory effects of M1-medi-
ated Fg binding on GAS pharyngeal epithelial cell binding, in
particular during stationary phase when SpeB expression is
maximal. Loss of SpeB in the invasive covRSmutant results in a
de facto increase in surface M1 expression and Fg binding dur-
ing bloodstream dissemination. Thus, intact CovRS regulation
limits both capsule and surfaceM1 expression (via SpeB degra-
dation) in the pharyngeal stage of infection, allowing maximal
epithelial cell adherence. CovRSmutation in vivo causes hyper-
encapsulation and increased M1 protein surface expression,
concurrently reducing pharyngeal binding while promoting
phagocyte resistance and contributing mechanisms to the sys-
temic dissemination and invasive infection for which theM1T1
clone is notorious. Our results provide further evidence of how
bacterial virulence factors can exert differential effects on host
cell interactions and disease pathogenesis based on the site and
stage of infection.
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